Airway diseases
State of the art sessionChairs: M. Humbert (Le Kremlin-Bicêtre, France), T. Geiser (Bern, Switzerland)
Aims: To evaluate the use of short-acting beta-2 agonist (SABA) monotherapy and oral corticosteroid (OCS) use in asthma; to describe concerns related to the use of inhaled corticosteroids (ICS) in COPD; and to determine the optimal inhalation device for patients with COPD.